Blue-Ribbon Panel Begins Process Of Closing Up Shop

At an April 1 meeting in Washington, D.C., the Carnegie Commission on Science, Technology, and Government formally began the process of going out of business. The commission's five-year charter ends June 30. The panel was convened in 1988 under the auspices of the Carnegie Corporation of New York to assess the ways in which policymakers take science and technology issues into account when making decisions. The blue-ribbon panel is cochaired by Nobel laureate Joshua Lederberg, former president

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The panel was convened in 1988 under the auspices of the Carnegie Corporation of New York to assess the ways in which policymakers take science and technology issues into account when making decisions. The blue-ribbon panel is cochaired by Nobel laureate Joshua Lederberg, former president of Rockefeller University, and William T. Golden, chairman of the board of the American Museum of Natural History in New York, who formerly served as a special consultant on scientific activities to President Harry Truman.

Included among the members of the commission and its advisory council are some of the United States' most prominent scientists, Republican Gerald Ford); three former U.S. senators (Republicans Charles McC. Mathias, Jr. of Maryland and Daniel Evans of Washington, as well as Democrat Lawton Chiles of Florida); three former U.S. representatives (Democrats John Brademas of Indiana and Paul Rogers of Florida, as well as Mathias, who served in the House ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Barbara Spector

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo